Bioventus (BVS) Change in Receivables (2020 - 2026)
Bioventus' (BVS) quarterly Change in Receivables came in at -$7.3 million in Q1 2026, up 18.73% YoY from -$6.2 million in Q1 2025, and down 288.22% on a QoQ basis from -$1.9 million in Q4 2025.
Bioventus (BVS) Change in Receivables (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Change in Receivables data on file, last reported at -$7.3 million in Q1 2026.
- Quarterly Change in Receivables rose 18.73% year-over-year to -$7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 979.05% YoY) and the FY2025 annual result came in at $916000.0, down 91.41% from the prior year.
- Change in Receivables fell to -$7.3 million in Q1 2026, from -$1.9 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $25.6 million in Q3 2022 to a low of -$17.1 million in Q3 2024.
- A 5-year average of $698882.4 and a median of -$1.8 million in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables soared 989.74% — and 2025, when it sank 559.86%.
- Tracing BVS's Change in Receivables over 5 years: stood at $4.8 million in 2022, then soared by 90.23% to $9.2 million in 2023, then tumbled by 36.99% to $5.8 million in 2024, then slumped by 132.54% to -$1.9 million in 2025, then sank by 288.22% to -$7.3 million in 2026.
- The last three Change in Receivables figures came in at -$7.3 million (Q1 2026), -$1.9 million (Q4 2025), and -$1.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | 17.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 17.94 Mn |
| Jun 27, 2026 | 17.94 Mn |
| Mar 28, 2026 | -7.32 Mn |
| Mar 28, 2026 | -7.32 Mn |
| Dec 31, 2025 | -1.89 Mn |
| Dec 31, 2025 | -1.89 Mn |
| Sep 27, 2025 | -1.82 Mn |
| Sep 27, 2025 | -1.82 Mn |
| Jun 28, 2025 | 13.63 Mn |
| Jun 28, 2025 | 13.63 Mn |
| Mar 29, 2025 | -9.00 Mn |
| Mar 29, 2025 | -9.00 Mn |
| Dec 31, 2024 | 5.79 Mn |
| Dec 31, 2024 | 5.79 Mn |
| Sep 28, 2024 | -17.06 Mn |
| Sep 28, 2024 | -17.06 Mn |
| Jun 29, 2024 | 19.98 Mn |
| Jun 29, 2024 | 19.98 Mn |
| Mar 30, 2024 | 1.96 Mn |
| Mar 30, 2024 | 1.96 Mn |